IRIS
MAPELLI, PAOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.979
NA - Nord America 2.327
AS - Asia 2.308
SA - Sud America 511
AF - Africa 49
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 4
Totale 8.198
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.218
RU - Federazione Russa 1.622
SG - Singapore 808
CN - Cina 721
BR - Brasile 404
IT - Italia 374
HK - Hong Kong 273
SE - Svezia 265
VN - Vietnam 236
DE - Germania 155
FR - Francia 123
ES - Italia 105
FI - Finlandia 99
GB - Regno Unito 86
IN - India 69
CA - Canada 61
BD - Bangladesh 43
AR - Argentina 41
PL - Polonia 35
MX - Messico 33
NL - Olanda 25
IE - Irlanda 23
TR - Turchia 23
ID - Indonesia 21
JP - Giappone 20
ZA - Sudafrica 20
AT - Austria 19
AU - Australia 19
EC - Ecuador 18
IQ - Iraq 15
CO - Colombia 13
CL - Cile 11
UZ - Uzbekistan 11
PK - Pakistan 10
PY - Paraguay 9
LT - Lituania 8
MA - Marocco 8
MD - Moldavia 8
MY - Malesia 7
PE - Perù 7
PT - Portogallo 7
SA - Arabia Saudita 7
UA - Ucraina 7
JO - Giordania 6
KE - Kenya 6
IL - Israele 5
NP - Nepal 5
PH - Filippine 5
AE - Emirati Arabi Uniti 4
BE - Belgio 4
IR - Iran 4
TN - Tunisia 4
AZ - Azerbaigian 3
CZ - Repubblica Ceca 3
DO - Repubblica Dominicana 3
RO - Romania 3
TW - Taiwan 3
UY - Uruguay 3
VE - Venezuela 3
BG - Bulgaria 2
BO - Bolivia 2
CR - Costa Rica 2
DZ - Algeria 2
EG - Egitto 2
ET - Etiopia 2
EU - Europa 2
GT - Guatemala 2
JM - Giamaica 2
KZ - Kazakistan 2
PA - Panama 2
PS - Palestinian Territory 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
AO - Angola 1
BW - Botswana 1
BZ - Belize 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CY - Cipro 1
GE - Georgia 1
HU - Ungheria 1
KR - Corea 1
LV - Lettonia 1
MR - Mauritania 1
PR - Porto Rico 1
PW - Palau 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
Totale 8.198
Salva come PNG Salva come JPEG
Città #
Dallas 582
Singapore 411
Moscow 329
Ashburn 312
Hong Kong 270
San Jose 241
Milan 167
Shanghai 144
Beijing 136
New York 131
Hefei 92
Valencia 86
Ho Chi Minh City 85
Lauterbourg 79
Munich 75
Lawrence 63
Princeton 63
Hanoi 55
Los Angeles 55
Turku 50
Boardman 46
Orem 43
Helsinki 41
São Paulo 37
Santa Clara 33
Chennai 24
Montreal 24
Rome 24
Warsaw 24
Dublin 23
Brooklyn 20
Frankfurt am Main 20
London 20
Atlanta 16
Chicago 16
Manchester 16
Poplar 15
Seattle 15
Stockholm 15
Tokyo 15
The Dalles 14
Toronto 14
Ankara 13
Columbus 13
Amsterdam 12
Denver 12
Johannesburg 12
Mumbai 12
Da Nang 11
Haiphong 11
Houston 11
Mexico City 11
Naples 11
Nuremberg 11
Phoenix 11
Washington 11
Guangzhou 10
New Delhi 10
Rio de Janeiro 10
Tashkent 10
Bexley 9
Falkenstein 9
San Francisco 9
Belo Horizonte 8
Buffalo 8
Council Bluffs 8
Fortaleza 8
Philadelphia 8
West Jordan 8
Dhaka 7
Hangzhou 7
Lappeenranta 7
Quito 7
Santiago 7
Secaucus 7
Vienna 7
Barnet 6
Boston 6
Canberra 6
Curitiba 6
Guayaquil 6
Lima 6
Shenzhen 6
Adelaide 5
Amman 5
Baghdad 5
Bogotá 5
Brasília 5
Can Tho 5
Guarulhos 5
Hamilton 5
Itaquaquecetuba 5
Kuala Lumpur 5
Lublin 5
Manaus 5
Paris 5
Pessano Con Bornago 5
Querétaro 5
Sydney 5
São João da Madeira 5
Totale 4.394
Salva come PNG Salva come JPEG
Nome #
18F-FDG PET/MRI in endometrial cancer: systematic review and meta-analysis 184
[68Ga]Ga-PSMA and [68Ga]Ga-RM2 PET/MRI vs. Histopathological Images in Prostate Cancer: A New Workflow for Spatial Co-Registration 181
68Ga-DOTATOC PET/MR imaging and radiomic parameters in predicting histopathological prognostic factors in patients with pancreatic neuroendocrine well-differentiated tumours 175
18F-FDG PET/CT May Predict Tumor Type and Risk Score in Gestational Trophoblastic Disease 169
11C-choline PET/CT predicts survival in prostate cancer patients with PSA < 1 NG/ml 163
A Single-Center Prospective Observational Study Investigating the Accuracy of Preoperative Diagnostic Procedures in the Assessment of Lymph Node Metastases in Nonfunctioning Pancreatic Neuroendocrine Tumors 160
Role of [68Ga]Ga-PSMA-11 PET radiomics to predict post-surgical ISUP grade in primary prostate cancer 157
68Ga-PSMA and 68Ga-DOTA-RM2 PET/MRI in Recurrent Prostate Cancer: Diagnostic Performance and Association with Clinical and Histopathological Data 156
[C-11]Choline PET/CT predicts survival in hormone-naive prostate cancer patients with biochemical failure after radical prostatectomy 154
68Ga-DOTA-peptides PET/MRI in pancreatico-duodenal neuroendocrine tumours: a flash pictorial essay on assets and lacks 143
18F-FAZA PET/CT in pretreatment assessment of hypoxic status in high-grade glioma: correlation with hypoxia immunohistochemical biomarkers 141
External validation of a convolutional neural network for the automatic segmentation of intraprostatic tumor lesions on 68Ga-PSMA PET images 129
18F-FAZA PET/CT in the Preoperative Evaluation of NSCLC: Comparison with 18F-FDG and Immunohistochemistry 127
null 126
Somatostatin receptor activity assessed by 68Ga-DOTATOC PET can preoperatively predict DAXX/ATRX loss of expression in well-differentiated pancreatic neuroendocrine tumors 125
[C-11] Choline Positron Emission Tomography/Computerized Tomography for Early Detection of Prostate Cancer Recurrence in Patients with Low Increasing Prostate Specific Antigen 125
Radiomics in pancreatic neuroendocrine tumors: methodological issues and clinical significance 125
Preliminary results of an ongoing prospective clinical trial on the use of68ga-psma and68ga-dota-rm2 pet/mri in staging of high-risk prostate cancer patients 124
Hybrid PET/MRI in Staging Endometrial Cancer: Diagnostic and Predictive Value in a Prospective Cohort 122
Recent developments in the diagnosis of pancreatic neuroendocrine neoplasms 120
18F-FAZA PET/CT Hypoxia Imaging of High-Grade Glioma Before and After Radiotherapy 118
18F-FAZA PET imaging in tumor hypoxia: A focus on high-grade glioma 118
Decoding the Heterogeneity of Malignant Gliomas by PET and MRI for Spatial Habitat Analysis of Hypoxia, Perfusion, and Diffusion Imaging: A Preliminary Study 117
11C-Choline PET/CT based Helical Tomotherapy as Treatment Approach for Bone Metastases in Recurrent Prostate Cancer Patients 117
Hypoxia pathway: 18F-FAZA 116
Preoperative assessment of lymph nodal metastases with [68Ga]Ga-DOTATOC PET radiomics for improved surgical planning in well-differentiated pancreatic neuroendocrine tumours 114
11C-or18F-Choline PET/CT for imaging evaluation of biochemical recurrence of prostate cancer 114
[¹⁸F]fluorodeoxyglucose positron emission tomography/computed tomography and trophoblastic disease: the gynecologist perspective 113
Diagnostic accuracy of fully hybrid [68Ga]Ga-PSMA-11 PET/MRI and [68Ga]Ga-RM2 PET/MRI in patients with biochemically recurrent prostate cancer: a prospective single-center phase II clinical trial 111
Clinical implication of multimodality imaging of aortic root intramural hematoma 110
PSMA PET in brain metastases: navigating diagnostic challenges– a thorough exploration 108
ASO Visual Abstract: Prognostic Significance and Predictors of Nodal Recurrence After Surgery for Nonfunctioning Pancreatic Neuroendocrine Tumors 108
State of the art of radiomic analysis in the clinical management of prostate cancer: A systematic review 107
Predictors of PSMA PET Positivity: Analysis in a Selected Cohort of Biochemical Recurrence Prostate Cancer Patients after Radical Prostatectomy 106
[Multi-modality imaging: mycotic abscess of a pericardial patch]. FT Imaging multimodale: ascesso micotico su patch di pericardio 103
Systematic Review and Metanalysis on the Role of Prostate-Specific Membrane Antigen Positron Emission Tomography/Magnetic Resonance Imaging for Intraprostatic Tumour Assessment 102
Role of Machine Learning (ML)-Based Classification Using Conventional 18F-FDG PET Parameters in Predicting Postsurgical Features of Endometrial Cancer Aggressiveness 100
Association of IgG4-related disease and systemic rheumatic disorders 100
Radiomics and artificial intelligence 98
Hypoxia PET imaging beyond 18F-FMISO in patients with high-grade glioma: 18F-FAZA and other hypoxia radiotracers 98
Prognostic Significance and Predictors of Nodal Recurrence After Surgery for Non-Functioning Pancreatic Neuroendocrine Tumors 95
PSMA and Choline PET for the Assessment of Response to Therapy and Survival Outcomes in Prostate Cancer Patients: A Systematic Review from the Literature 93
The Challenge of External Generalisability: Insights from the Bicentric Validation of a [68Ga]Ga-PSMA-11 PET Based Radiomics Signature for Primary Prostate Cancer Characterisation Using Histopathology as Reference 90
Synergic role of preoperative 18F-fluorodeoxyglucose PET and MRI parameters in predicting histopathological features of endometrial cancer 90
Dual tracer 68Ga-DOTATOC and 18F-FDG PET/computed tomography radiomics in pancreatic neuroendocrine neoplasms: An endearing tool for preoperative risk assessment 85
Choline PET/CT features to predict survival outcome in high risk prostate cancer restaging: a preliminary machine-learning radiomics study 84
Advancements in Neuroendocrine Neoplasms: Imaging and Future Frontiers 79
Concomitant Lung Cancer and Gastrointestinal Stromal Tumor: First Report of Hypoxia Imaging With 18F-FAZA PET/CT 76
18F-FDG PET/CT for Early Postradiotherapy Assessment in Solitary Bone Plasmacytomas 75
Imaging in evaluation of response to neo-adjuvant treatment 74
The potential role of osteoporosis in unspecific [18F]PSMA-1007 bone uptake 72
Hypoxia and Amino Acid Imaging of High-Grade Glioma18F-FAZA PET/CT and 11C-Methionine PET/MRI 72
Radiation treatment of lymph node recurrence from prostate cancer: Is 11C-choline PET/CT predictive of survival outcomes? 68
Dual tracer 68ga-dotatoc and 18f-fdg pet improve preoperative evaluation of aggressiveness in resectable pancreatic neuroendocrine neoplasms 68
Nuclear medicine in prostate cancer management 67
The role of 18F-FAZA PET/CT in detecting lymph node metastases in renal cell carcinoma patients: a prospective pilot trial 67
Prognostic role of FDG PET-derived parameters in preoperative staging of endometrial cancer 66
PET/MRI and prostate cancer 64
Combined 68Ga-DOTA-peptides and 18F-FDG PET in the diagnostic work-up of neuroendocrine neoplasms (NEN) 64
Early variation of 18-fluorine-labelled fluorodeoxyglucose PET-derived parameters after chemoradiotherapy as predictors of survival in locally advanced pancreatic carcinoma patients 61
Pancreatic metastases from primary ileal NET only detected by 68Ga-DOTATOC PET/CT 59
Hybrid cardiac PET/MR: the value of multiparametric assessment in cardiac sarcoidosis 58
FDG PET-derived parameters as prognostic tool in progressive malignant pleural mesothelioma treated patients 57
The role of positron emission tomography/computed tomography (Pet/ct) for staging and disease response assessment in localized and locally advanced pancreatic cancer 55
PET imaging for lymph node dissection in prostate cancer 54
Evaluation of prostate cancer with11C-Choline PET/CT for treatment planning, response assessment, and prognosis 54
The relationship between local recurrences and distant metastases in prostate cancer: can11C-choline PET/CT contribute to understand the link? 53
PET/MRI 52
Hypoxia18F-FAZA PET/CT imaging in lung cancer and high-grade glioma: open issues in clinical application 52
PET/MRI in Neuroendocrine Tumours: Blessings and Curses 52
Role of 18F-FDG PET in the management of gestational trophoblastic neoplasia 51
Incidental Finding of Parathyroid Adenoma With C-11-Choline PET/CT 51
POSITRON EMISSION TOMOGRAPHY/MAGNETIC RESONANCE IMAGING 49
Lymph nodal metastases: diagnosis and treatment 49
Sarcoidosis mimicking metastatic gynaecological malignancies: A diagnostic and therapeutic challenge? 48
Initial prostate cancer diagnosis and disease staging - The role of choline-PET-CT 48
Clinical PET imaging of tumour hypoxia in lung cancer 48
DETECTION OF BONE METASTASES AND EVALUATION OF THERAPY RESPONSE IN PROSTATE CANCER PATIENTS BY RADIOLABELLED CHOLINE PET/CT 48
FDG-PET/CT predicts outcome in oropharingeal carcinoma patients undergoing intensity modulated radiation therapy with dose escalation to FDG-avid tumour volumes 47
PET/MRI in gynecological tumors 46
Imaging biomarkers in prostate cancer: role of PET/CT and MRI 46
Negative 11C-choline PET/computed tomography imaging in restaging of patients with prostate cancer with serum prostate-specific antigen values >20 ng/mL 46
Detection of bone metastases and evaluation of therapy response in prostate cancer patients by radiolabelled choline PET/CT 45
Prostate cancer recurrence: can PSA guide imaging? 44
Diagnostic Accuracy of Fully Hybrid PET/MRI with [68 Ga]Ga-PSMA-11 and [68 Ga]Ga-RM2 in Detecting Primary Prostate Cancer: A Phase 2 Trial with Histology as Gold Standard 44
Predictive value of pre-therapy 18F-FDG PET/CT for the outcome of 18F-FDG PET-guided radiotherapy in patients with head and neck cancer 43
Imaging biomarkers in ovarian cancer: the role of ¹⁸F-FDG PET/CT 43
Optical imaging in lung cancer—follow the light, towards molecular imaging–guided precision surgery 43
The relationship between gleason score and 11c-choline pet/ct positive detection rate in prostate cancer patients with biochemical failure after radical prostatectomy: biological and methodological factors 42
[18F]FDG PET/MRI in Endometrial Cancer: Prospective Evaluation of Preoperative Staging, Molecular Characterization and Prognostic Assessment 42
Spinal cord involvement secondary to non-Hodgkin's lymphoma identified by F-18-FDG PET/CT 42
Reply to the letter "Choline PET/CT compared with bone scintigraphy in the detection of bone metastases in prostate cancer patients" 41
Erdheim-Chester Disease Imaging-Guided Therapeutic Approach 40
PET guidance in prostate cancer radiotherapy: Quantitative imaging to predict response and guide treatment 40
Unusual presentation of sarcoid-like reaction on bone marrow level associated with mediastinal lymphadenopathy on F-18-FDG-PET/CT resembling an early recurrence of Hodgkin's Lymphoma 38
TECNICHE, METODOLOGIE, APPLICAZIONI DIAGNOSTICA PER IMMAGINI 38
High-grade endometrial cancer: value of [F-18]FDG PET/CT in preoperative staging 37
Data-Driven Motion Correction of 11C-Methionine PET Images on a Cohort of Pediatric Patients With Brain Tumor in a PET/MRI Study 27
null 23
Per-Lesion Assessment of Individual MRI Sequences and 68Ga-DOTATATE PET in Neuroendocrine Liver Metastases 16
Totale 8.405
Salva come PNG Salva come JPEG
Categoria #
all - tutte 42.294
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.294
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022106 0 6 0 31 11 5 9 11 14 11 2 6
2022/2023526 145 95 42 30 20 49 39 52 9 22 3 20
2023/2024604 44 27 109 64 40 91 22 56 9 20 33 89
2024/20251.475 144 33 43 41 88 113 264 140 173 145 122 169
2025/20265.636 392 378 725 710 447 172 447 406 1.496 351 112 0
Totale 8.417